Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Gilead Sciences Inc (GILD)
Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,253,584
  • Shares Outstanding, K 1,246,042
  • Annual Sales, $ 27,281 M
  • Annual Income, $ 4,592 M
  • 60-Month Beta 0.29
  • Price/Sales 3.62
  • Price/Cash Flow 8.80
  • Price/Book 4.43
Trade GILD with:

Options Overview Details

View History
  • Implied Volatility 17.96% ( -2.38%)
  • Historical Volatility 23.67%
  • IV Percentile 5%
  • IV Rank 11.44%
  • IV High 29.79% on 10/27/23
  • IV Low 16.44% on 12/05/23
  • Put/Call Vol Ratio 0.60
  • Today's Volume 5,357
  • Volume Avg (30-Day) 8,540
  • Put/Call OI Ratio 1.02
  • Today's Open Interest 243,525
  • Open Int (30-Day) 240,765

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 1.79
  • Number of Estimates 12
  • High Estimate 2.04
  • Low Estimate 1.64
  • Prior Year 1.67
  • Growth Rate Est. (year over year) +7.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.99 +7.06%
on 11/16/23
80.18 -1.20%
on 12/06/23
+1.31 (+1.69%)
since 11/08/23
3-Month
72.87 +8.71%
on 10/03/23
82.59 -4.09%
on 11/03/23
+3.21 (+4.23%)
since 09/08/23
52-Week
72.87 +8.71%
on 10/03/23
89.74 -11.73%
on 12/13/22
-10.26 (-11.46%)
since 12/08/22

Most Recent Stories

More News
GILD, BIIB, and KRTX: Biotech Buy, Hold, or Sell?

Rising healthcare needs, significant investments in R&D, robust drug pipeline, and use of advanced technology are some factors driving the biotech industry’s growth. Amid this favorable backdrop, let’s...

BIIB : 239.49 (+0.15%)
GILD : 79.22 (+1.50%)
KRTX : 205.85 (-0.19%)
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 63.30 (-0.33%)
ONCY : 1.4050 (+0.36%)
ONC.TO : 1.92 (+0.52%)
DSNKY : 27.5150 (-2.53%)
GILD : 79.22 (+1.50%)
ARAY : 2.66 (+0.38%)
2 Biotech Stocks You Can Buy and Hold for the Next Decade

These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.

SNY : 46.33 (+0.59%)
GILD : 79.22 (+1.50%)
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later

There's no time like the present to buy these stocks.

ABBV : 150.03 (+1.39%)
LLY : 596.54 (+1.41%)
GILD : 79.22 (+1.50%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 63.30 (-0.33%)
ONCY : 1.4050 (+0.36%)
ONC.TO : 1.92 (+0.52%)
DSNKY : 27.5150 (-2.53%)
GILD : 79.22 (+1.50%)
ARAY : 2.66 (+0.38%)
Vertex Pharmaceuticals (VRTX) Post-Earnings Analysis: Is It Time to Buy the Stock?

After a solid third-quarter earnings report, does Vertex Pharmaceuticals (VRTX) deserve a place in your portfolio? Let’s look at its financial metrics to gauge its prospects… Vertex Pharmaceuticals...

CORT : 26.74 (+0.04%)
GILD : 79.22 (+1.50%)
OTSKY : 19.3150 (-2.10%)
VRTX : 350.85 (-0.88%)
Global Anal Cancer Market Size Expected to Reach $1.24 Billion In 2028 as Treatments Advance

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:BMY),(NASDAQ:GILD),(NYSE:MRK),(NYSE:PFE) EQNX::TICKER_END

ONCY : 1.4050 (+0.36%)
ONC.TO : 1.92 (+0.52%)
BMY : 50.46 (+0.60%)
GILD : 79.22 (+1.50%)
MRK : 103.68 (-0.19%)
PFE : 28.78 (+0.52%)
Buying the dip in high-yield Gilead Sciences 

Pharma stock Gilead Sciences is well-positioned for the next few years with a growing core business, a healthy pipeline, and cash flow to sustain capital return

GILD : 79.22 (+1.50%)
Gilead Sciences (GILD) Q3 2023 Earnings Call Transcript

GILD earnings call for the period ending September 30, 2023.

GILD : 79.22 (+1.50%)
Gilead: Q3 Earnings Snapshot

Gilead: Q3 Earnings Snapshot

GILD : 79.22 (+1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 81.26
2nd Resistance Point 80.53
1st Resistance Point 79.29
Last Price 79.22
1st Support Level 77.33
2nd Support Level 76.60
3rd Support Level 75.36

See More

52-Week High 89.74
Fibonacci 61.8% 83.29
Fibonacci 50% 81.30
Fibonacci 38.2% 79.31
Last Price 79.22
52-Week Low 72.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar